Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials

This publication has 21 references indexed in Scilit:

• ABSORB Biodegradable Stents Versus Second-Generation Metal Stents
  JACC: Cardiovascular Interventions, 2014
• Long-Term Safety of an Everolimus-Eluting Bioresorbable Vascular Scaffold and the Cobalt-Chromium XIENCE V Stent in a Porcine Coronary Artery Model
  Circulation: Cardiovascular Interventions, 2014
• Dynamics of vessel wall changes following the implantation of the Absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months
  EuroIntervention, 2014
• Amsterdam Investigator–initiateD Absorb strategy all-comers trial (AIDA trial): A clinical evaluation comparing the efficacy and performance of ABSORB everolimus-eluting bioresorbable vascular scaffold strategy vs the XIENCE family (XIENCE PRIME or XIENCE Xpedition) everolimus-eluting coronary stent strategy in the treatment of coronary lesions in consecutive all-comers: Rationale and study design
  American Heart Journal, 2014
• Bioresorbable scaffolds: rationale, current status, challenges, and future
  European Heart Journal, 2013
• An international registry of systematic-review protocols
  The Lancet, 2011
• Much ado about nothing: a comparison of the performance of meta‐analytical methods with rare events
  Statistics in Medicine, 2006
• Measuring inconsistency in meta-analyses
  BMJ, 2003
• Investigating and dealing with publication and other biases in meta-analysis
  BMJ, 2001
• On alleged gains in power from lowerP‐values
  Statistics in Medicine, 1989